MedTrace Logo

Clinical Trial to Evaluate the Effect of a Probiotic in Acne

NCT04570319 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2023-02-16

No results posted yet for this study

Summary

A 12-week randomized, multicenter and double-blind, placebo-controlled study to evaluate the effect of a probiotic in the clinical and subjective evolution of acne in adolescent and adult patients.

Conditions

  • Acne
  • Acne Vulgaris

Interventions

DIETARY_SUPPLEMENT

Probiotic Bths-08

A capsule containing the probiotic blend (dietary supplement), administered once daily for 12 weeks

DIETARY_SUPPLEMENT

Placebo

A capsule containing the placebo (dietary supplement), administered one daily for 12 weeks

Sponsors & Collaborators

  • Bionou Research, S.L.

    lead NETWORK

Principal Investigators

  • Vicente Navarro-Lopez, PhD; MD · Universidad Católica San Antonio de Murcia (UCAM)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-29
Primary Completion
2022-07-21
Completion
2022-09-20

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04570319 on ClinicalTrials.gov